Cancer patients: large drops in anxiety, still seen at six months
In a randomized, double-blind crossover trial, 51 people with life-threatening cancer and symptoms of depression or anxiety each had two sessions five weeks apart, one with a very low placebo-like dose and one with a high dose, in random order. After the high-dose session, clinician-rated and self-rated anxiety and depression fell sharply, and quality of life, sense of meaning, and optimism improved. Six months later, about 80 percent still showed clinically significant reductions in depressed mood and anxiety.
Worth knowing
Everyone had cancer-related distress, so this does not show the same result for everyday anxiety. It was one site, with careful preparation and support, and the experience is hard to disguise from the person having it. The six-month results come after both groups had received the high dose, so they are not a controlled comparison.